131 related articles for article (PubMed ID: 37846678)
1. [Effects of Cytokines on Early Death in Patients with Newly Diagnosed Acute Promyelocytic Leukemia].
Zhao SX; Ge YY; Li ZZ; He HP; Shen CM; Shi KQ; Yang TH; DU YY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1315-1321. PubMed ID: 37846678
[TBL] [Abstract][Full Text] [Related]
2. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
Zhao S; Ge Y; Li Z; Yang T
Front Immunol; 2023; 14():1100151. PubMed ID: 37063881
[TBL] [Abstract][Full Text] [Related]
3. Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia.
Wen J; Xu F; Zhou Q; Shi L; Liu Y; Yue J; Zhang Y; Liang X
BMC Cancer; 2023 Jan; 23(1):27. PubMed ID: 36611025
[TBL] [Abstract][Full Text] [Related]
4. Predictive values of plasma TNFα and IL-8 for intracranial hemorrhage in patients with acute promyelocytic leukemia.
Dong F; Chen L; Zhao C; Li X; Tan Y; Song H; Jin W; Zhu H; Zhang Y; Xue K; Li J; Wang K
Front Med; 2022 Dec; 16(6):909-918. PubMed ID: 36094653
[TBL] [Abstract][Full Text] [Related]
5. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
6. Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia.
Li S; Gao Y; Li F; Zheng Y; Su Y
Ann Hematol; 2023 Apr; 102(4):787-794. PubMed ID: 36750485
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome.
Yamamoto de Almeida L; Pereira-Martins DA; Lima ASG; Baggio MS; de Araujo Koury LC; Lange AP; Bassi SC; Scheucher PS; Rego EM
BMC Cancer; 2020 Aug; 20(1):821. PubMed ID: 32859169
[TBL] [Abstract][Full Text] [Related]
8. New onset acute promyelocytic Leukemia during pregnancy: report of 2 cases.
Li H; Han C; Li K; Li J; Wang Y; Xue F
Cancer Biol Ther; 2019; 20(4):397-401. PubMed ID: 30453810
[TBL] [Abstract][Full Text] [Related]
9. Hyperfibrinolysis Is an Important Cause of Early Hemorrhage in Patients with Acute Promyelocytic Leukemia.
Song YH; Qiao C; Xiao LC; Zhang R; Lu H-
Med Sci Monit; 2018 May; 24():3249-3255. PubMed ID: 29771870
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
[TBL] [Abstract][Full Text] [Related]
11. Low platelet count is potentially the most important contributor to severe bleeding in patients newly diagnosed with acute promyelocytic leukemia.
Song YH; Peng P; Qiao C; Zhang R; Li JY; Lu H
Onco Targets Ther; 2017; 10():4917-4924. PubMed ID: 29062237
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia.
Xiao M; Zhou P; Liu Y; Wei S; Li D; Li W; Niu X; Niu J; Zhang Y; Cao W; Liu B; Wang X; Bai Y; Sun K
Thromb Res; 2022 Feb; 210():33-41. PubMed ID: 34998209
[TBL] [Abstract][Full Text] [Related]
13. Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG.
Kungwankiattichai S; Owattanapanich W; Rattanathammethee T; Rattarittamrong E; Chanswangphuwana C; Polprasert C; Limvorapitak W; Saengboon S; Niparuck P; Puavilai T; Julamanee J; Saelue P; Wanitpongpun C; Prayongratana K; Sriswasdi C; Nakhakes C
Hematology; 2023 Dec; 28(1):2191462. PubMed ID: 36951362
[TBL] [Abstract][Full Text] [Related]
14. Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia.
Ma G; Liu F; Lv L; Gao Y; Su Y
Ann Hematol; 2013 May; 92(5):645-52. PubMed ID: 23344645
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for early in-hospital death in patients who developed coagulopathy during induction therapy for acute promyelocytic leukemia: a nationwide analysis in Japan.
Matsuda K; Jo T; Toyama K; Nakazaki K; Matsui H; Fushimi K; Yasunaga H; Kurokawa M
Ann Hematol; 2021 Oct; 100(10):2613-2619. PubMed ID: 34308494
[TBL] [Abstract][Full Text] [Related]
16. Effect of arsenic trioxide on cytokine expression by acute promyelocytic leukemia cells.
Jiang G; Bi K; Tang T; Zhang Y; Ren H; Jiang F; Ren Q; Zhen G; Liu C; Peng J; Guo G; Liu X; Tian Z
Chin Med J (Engl); 2003 Nov; 116(11):1639-43. PubMed ID: 14642127
[TBL] [Abstract][Full Text] [Related]
17. Advances in the management of coagulopathy in acute promyelocytic leukemia.
Sanz MA; Montesinos P
Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
[TBL] [Abstract][Full Text] [Related]
18. All-trans retinoic acid and in vitro cytokine production by acute promyelocytic leukemia cells.
Visani G; Tosi P; Ottaviani E; Zaccaria A; Baccini C; Manfroi S; Pastano R; Remiddi C; Morelli A; Molinari AL; Zanchini R; Tura S
Eur J Haematol; 1996 Oct; 57(4):301-6. PubMed ID: 8982293
[TBL] [Abstract][Full Text] [Related]
19. The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia.
Sun YX; Kong HL; Liu CF; Yu S; Tian T; Ma DX; Ji CY
Hum Immunol; 2014 Feb; 75(2):113-8. PubMed ID: 24269703
[TBL] [Abstract][Full Text] [Related]
20. Cytokine profiles in patients with newly diagnosed multiple myeloma: Survival is associated with IL-6 and IL-17A levels.
Gu J; Huang X; Zhang Y; Bao C; Zhou Z; Jin J
Cytokine; 2021 Feb; 138():155358. PubMed ID: 33183958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]